NorthWest Biotherapeutics Inc (NWBO)

[Adam_Feuerstein]

Linda Powers, with all her self dealings and lack of transparency, treats NWBO as if it was a private company. But NWBO is a public company. This means NWBO must abide by securities laws governing the conduct of publicly traded companies.

This means that NWBO is required to make prompt public disclosures of material news and information.

NWBO has not submitted a BLA of any kind. Had NWBO submitted a BLA of any kind, the company could not keep it secret. That's a material, disclosable event.

NWBO has also not completed the phase 3 study in secret. Again, completing the study, having data in hand, would be material information requiring disclosure.

I know many of you love to conjure up ways in which NWBO is different or special from its biotech peers, but it's not. The same rules apply. Look around. Companies routinely disclose clinical and regulatory milestones like the completion of trial enrollment, interim or final analysis triggers, actual top-line data results (!!!) and submissions of BLAs or NDAs to the FDA.

NWBO has not done any of these things because none of these events have taken place yet.

NWBO is almost out of cash again. The stock is sitting a penny above its all-time low.

I enjoy reading this message board.